Skip to main content
Top

Pituitary

Issue 2/2015

Cushing Disease: A Comprehensive Update

Content (17 Articles)

Clinical and biochemical manifestations of Cushing’s

Georgia Ntali, Ashley Grossman, Niki Karavitaki

Open Access

Comorbidities in Cushing’s disease

S. T. Sharma, L. K. Nieman, R. A. Feelders

Quality of life in Cushing’s syndrome

Alicia Santos, Iris Crespo, Anna Aulinas, Eugenia Resmini, Elena Valassi, Susan M. Webb

Diagnosis of Cushing’s disease

Eleni Daniel, John D. C. Newell-Price

Surgical management of Cushing’s disease

Robert F. Dallapiazza, Edward H. Oldfield, John A. Jane Jr.

Current status on histological classification in Cushing’s disease

Luis V. Syro, Fabio Rotondo, Michael D. Cusimano, Antonio Di Ieva, Eva Horvath, Lina M. Restrepo, Min Wong, Donald W. Killinger, Harley Smyth, Kalman Kovacs

Approach to the postoperative patient with Cushing’s disease

Martin J. Rutkowski, Jonathan D. Breshears, Sandeep Kunwar, Manish K. Aghi, Lewis S. Blevins

Medical combination therapies in Cushing’s disease

Lucio Vilar, Luciana A. Naves, Márcio C. Machado, Marcello D. Bronstein

Update on radiation therapy in patients with Cushing’s disease

Nicholas A. Tritos, Beverly M. K. Biller

A pitfall in diagnosing Cushing’s disease: ectopic ACTH-producing pituitary adenoma in the sphenoid sinus

J. Flitsch, S. M. Schmid, C. Bernreuther, B. Winterberg, M. M. Ritter, H. Lehnert, T. Burkhardt

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine